Cancer survivors in the United States who report diminished quality of life "more than doubled" in the past two decades, according to a study published May 11 in JAMA Oncology.
Oncology
Tampa-based Moffitt Cancer Center appointed Xavier Avat as chief business officer, the Business Observer reported June 5.
Continuing immunotherapy treatments when a renal cancer patient's disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology.
Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.
Advertisement
GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.
Here are the 10 most-read oncology stories published by Becker's in May:
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Screenings that were delayed due to COVID-19 are likely to contribute to an exponential increase in cancer diagnosis totals over the next few years, experts say.